Is Percutaneous Ethanol Injection a Useful Alternative for the Treatment of the Cold Benign Thyroid Nodule? Five Years' Experience
- 1 October 1997
- journal article
- research article
- Published by Mary Ann Liebert Inc in Thyroid®
- Vol. 7 (5), 699-704
- https://doi.org/10.1089/thy.1997.7.699
Abstract
We describe our 5-year experience with percutaneous ethanol injection (PEI) for the treatment of cold benign thyroid nodules and report its efficacy and side effects. Fifty-four euthyroid outpatients (aged 44.8 ± 12.7 years, mean ± SD) were divided into two groups matched for sex, age, and nodule volume: 27 patients treated only by PEI and 27 patients treated additionally with levothyroxine-suppressive therapy (median follow-up: 24 months, range 6–48). Mean pretreatment nodule volume was 21.0 mL (range 5.4–54.6). Ethanol (1.3 ± 0.6 mL/mL nodule volume) was injected under sonographic control in 4 to 13 weekly sessions (mean 7.4). PEI therapy was well tolerated by all patients. At the end of treatment, nodule volume was 7.7 ± 5.7 mL (p =.0001). A further significant shrinkage was obtained at 1-year follow-up (4.4 ± 3.8 mL; p <.05). No significant differences in nodule reduction were observed between the levothyroxine treated or untreated group and between patients with pretreatment nodule volume smaller or larger than 15 mL. Our study confirms the efficacy and safety of PEI in inducing volume shrinkage of cold benign thyroid nodules. Overall our data suggest that PEI may become an interesting alternative for patients with surgical indications, if they refuse surgery or are poor surgical risks, or eventually demand treatment for aesthetic purposes. It may also be considered when levothyroxine therapy is contraindicated or ineffective.Keywords
This publication has 24 references indexed in Scilit:
- Treatment of solitary autonomous thyroid nodules by percutaneous ethanol injection: results of an Italian multicenter study. The Multicenter Study GroupJournal of Clinical Endocrinology & Metabolism, 1996
- Percutaneous Ethanol Injection (PEI): What Is Its Role in the Treatment of Benign Thyroid Nodules?Thyroid®, 1995
- Possible Limited Bone Loss with Suppressive Thyroxine Therapy Is Unlikely to Have Clinical RelevanceThyroid®, 1995
- Percutaneous aspiration and ethanol sclerotherapy for thyroid cystsJournal of Clinical Endocrinology & Metabolism, 1994
- A prospective randomized trial of levothyroxine suppressive therapy for solitary thyroid nodulesClinical Endocrinology, 1993
- Morbidity in patients on l-thyroxine: a comparison of those with a normal TSH to those with a suppressed TSHClinical Endocrinology, 1992
- Long-term thyroxine treatment and bone mineral densityThe Lancet, 1992
- Suppressive therapy with levothyroxinefor solitary thyroid nodulesClinical Endocrinology, 1992
- THE LONG‐TERM OUTCOME OF THYROIDECTOMY FOR SPORADIC NON‐TOXIC GOITREClinical Endocrinology, 1989
- Suppressive Therapy with Levothyroxine for Solitary Thyroid NodulesThe New England Journal of Medicine, 1987